GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Liquidia Corp (FRA:LT4) » Definitions » 3-Year EPS without NRI Growth Rate

Liquidia (FRA:LT4) 3-Year EPS without NRI Growth Rate : 12.60% (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Liquidia 3-Year EPS without NRI Growth Rate?

Liquidia's EPS without NRI for the three months ended in Mar. 2024 was €-0.36.

During the past 3 years, the average EPS without NRI Growth Rate was 12.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was 33.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 8 years, the highest 3-Year average EPS without NRI Growth Rate of Liquidia was 54.80% per year. The lowest was 6.40% per year. And the median was 28.30% per year.


Competitive Comparison of Liquidia's 3-Year EPS without NRI Growth Rate

For the Biotechnology subindustry, Liquidia's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Liquidia's 3-Year EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Liquidia's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Liquidia's 3-Year EPS without NRI Growth Rate falls into.



Liquidia 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Liquidia  (FRA:LT4) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Liquidia 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Liquidia's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Liquidia (FRA:LT4) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Liquidia Corp (FRA:LT4) » Definitions » 3-Year EPS without NRI Growth Rate
Traded in Other Exchanges
Address
419 Davis Drive, Suite 100, Morrisville, NC, USA, 27560
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH). It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles designed to improve the safety, efficacy, and performance of a wide range of therapies. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension.

Liquidia (FRA:LT4) Headlines

No Headlines